Curispas-M Tablet
By Curispas-M
Rx
10 Tablet in a Strip

Composition
Dicyclomine(10mg) + Mefenamic Acid(250mg)

Manufacturer - Curelab Healthcare
B No. 19/GF, Satyam Estate, Steel Town, Behind-HOF, Sarkhej Bavla Highway, Moraiya, Ahmedabad, Gujarat, 382213, India

Expires on or after
September, 2025

liver
When using Curispas-M Tablet, it is important to be cautious if you have liver disease. It may be necessary to adjust the dosage of the tablet in such cases. It is advised to consult with your doctor regarding the use of Curispas-M Tablet if you have liver issues.

kidney
Curispas-M Tablet needs caution in kidney disease patients. Dosage adjustment may be necessary. Avoid in severe kidney disease. Consulting your doctor is advised.

alcohol
When taking Curispas-M Tablet, be cautious if consuming alcohol. It's recommended to consult with your doctor regarding alcohol intake.

driving
Caution while driving is important when taking Curispas-M Tablet. If you have symptoms that make it hard to focus or react, avoid driving. It is uncertain if Curispas-M Tablet impacts driving ability.

pregnancy
It is better to consult your doctor before using Curispas-M Tablet during pregnancy as information regarding its safety during this time is not available.

breastfeeding
It is better to consult your doctor before using Curispas-M Tablet during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | PAIN ANALGESICS |
Action Class | - |
₹31
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024